Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Common Equity (2020 - 2025)

Privia Health has reported Common Equity over the past 6 years, most recently at $790.9 million for Q4 2025.

  • Quarterly results put Common Equity at $790.9 million for Q4 2025, up 15.73% from a year ago — trailing twelve months through Dec 2025 was $790.9 million (up 15.73% YoY), and the annual figure for FY2025 was $790.9 million, up 15.73%.
  • Common Equity for Q4 2025 was $790.9 million at Privia Health, up from $762.8 million in the prior quarter.
  • Over the last five years, Common Equity for PRVA hit a ceiling of $790.9 million in Q4 2025 and a floor of $149.4 million in Q1 2021.
  • Median Common Equity over the past 5 years was $581.2 million (2023), compared with a mean of $563.2 million.
  • Biggest five-year swings in Common Equity: surged 229.44% in 2021 and later increased 11.91% in 2024.
  • Privia Health's Common Equity stood at $450.2 million in 2021, then grew by 15.3% to $519.0 million in 2022, then increased by 17.02% to $607.4 million in 2023, then grew by 12.52% to $683.4 million in 2024, then grew by 15.73% to $790.9 million in 2025.
  • The last three reported values for Common Equity were $790.9 million (Q4 2025), $762.8 million (Q3 2025), and $733.5 million (Q2 2025) per Business Quant data.